Myself and Kristy Piccinini, PhD from FTI Consulting published a new commentary in The Evidence Base titled “Perspectives from the Healthcare Economist: Why CMS/AHIP’s prior authorization changes won’t hurt payers.”
Dr.
Shafrin and Dr. Piccinini share their insights in this Guest Column examining
the implications of recent CMS/AHIP prior authorization reforms and why these
changes are unlikely to negatively impact payers. They explore
key questions such as:
- Who benefits most from the proposed prior authorization reform?
- Will reduced prior authorization be a good thing for society?
You can read the full article here.
